How NMPA Reviews Bioequivalence Studies
How NMPA Reviews Bioequivalence Studies Understanding NMPA’s Review of Bioequivalence Studies in China Introduction Bioequivalence (BE) studies are a cornerstone of generic drug development, providing evidence that a generic formulation performs comparably to a reference drug. In China, the National Medical Products Administration (NMPA) has significantly reformed BE requirements to improve generic drug quality and…